- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: her2 positive locally advanced breast cancer
Total 103272 results
-
Providence Health & ServicesSeagen Inc.WithdrawnBreast Cancer Stage IVUnited States
-
Spectrum Pharmaceuticals, IncTerminatedBreast CancerUnited States
-
Harold J. Burstein, MD, PhDMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteBreast Cancer Research Foundation; Array BioPharmaCompletedAdvanced HER2-positive Breast Cancer | Brain Metastases From HER2 and Breast CancerUnited States
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHR-positive, HER2-negative and PIK3CA Mutation Advanced Breast CancerChina
-
Iambic Therapeutics, IncRecruiting
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Shanghai General Hospital, Shanghai Jiao Tong University...NanoMab Technology (UK) LimitedCompleted
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States
-
Pamela MunsterPfizer; Xynomic Pharmaceuticals, Inc.WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; GlaxoSmithKline; Brigham and Women's Hospital; North...CompletedBreast Cancer | Stage IV Breast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalActive, not recruitingCAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerGastric Cancer | Esophageal CancerUnited States
-
Ottawa Hospital Research InstituteCompleted
-
Fondazione del Piemonte per l'OncologiaUnknown
-
Peking UniversityRecruitingHER2-positive Locally Advanced Resectable Gastric CancerChina
-
University of VirginiaMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Fudan UniversityCompleted
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHER2-positive Recurrent / Metastatic Breast CancerChina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2/Neu-positive Breast CancerUnited States
-
University of MiamiNational Cancer Institute (NCI)Not yet recruitingAdvanced Breast Cancer | HER2-positive Breast CancerUnited States
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-negative Breast CancerBrazil
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
ETOP IBCSG Partners FoundationCompleted
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent... and other conditionsUnited States
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Biliary Tract CancerChina
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Eisai Inc.CompletedBreast CancerUnited States
-
RemeGen Co., Ltd.RecruitingAdvanced Melanoma | Melanoma, Stage II | HER2-positiveChina
-
UNC Lineberger Comprehensive Cancer CenterIncyte CorporationWithdrawnBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | HER2-positive Breast Cancer
-
SOLTI Breast Cancer Research GroupTerminated
-
Samsung Medical CenterActive, not recruitingGastric CancerKorea, Republic of
-
Shanghai Miracogen Inc.RecruitingLocally Advanced Gastric Cancer | Metastatic HER2 Positive Gastroesophageal Junction CancerChina
-
Alliance Foundation Trials, LLC.Pfizer; Breast International Group; NSABP Foundation Inc; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingBreast CancerUnited States, Spain, Italy, Ireland, United Kingdom, Australia, Germany, Japan, Portugal, Taiwan, Canada, Israel, Netherlands, Switzerland, Belgium, Austria, Hungary, Korea, Republic of, Mexico, Poland, Sweden
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
UNICANCERARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research GroupActive, not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusFrance
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedHER2-positive Breast CancerChina
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Jennifer Lee Caswell-JinNational Cancer Institute (NCI); QED Therapeutics, Inc.TerminatedBreast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
Latin American Cooperative Oncology GroupRoche Pharma AG; OncoclínicasNot yet recruitingBreast Cancer | HER2-positive Breast CancerBrazil
-
Menoufia UniversityRecruitingLocally Advanced Breast Cancer | Intermittent FastingEgypt
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedBreast CancerUnited States
-
Washington University School of MedicineWithdrawn
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany